Last reviewed · How we verify
NCT05188599
Isokinetic Parameters and the Amputee Mobility Predictor Scale
trial testing İsokinetic assessment in Amputation, Traumatic in 43 participants. Completed in 29 April 2022.
29 April 2022
Quick facts
| Lead sponsor | Gaziler Physical Medicine and Rehabilitation Education and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 1 March 2022 |
| Primary completion | 29 April 2022 |
| Estimated completion | 29 April 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- İsokinetic assessment
Conditions studied
- Amputation, Traumatic — all drugs for Amputation, Traumatic →
Sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Who can join
Adults 18 to 65, any sex, with Amputation, Traumatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is very limited research examining isokinetic parameters and activity level in patients with amputation.. Therefore, the aims of this study were to illustrate isokinetic measurements including strength and proprioception and to analyze the correlation between those isokinetic parameters and activity level and to predict amputee mobility score. It is hypothesized that muscle strength and proprioception were associated with activity level and could be used to estimate amputee mobility scale score in patients with amputation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05188599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amputation, Traumatic
Currently open trials in the same condition.
- NCT06433648 — Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait · NA · recruiting
- NCT05297266 — Early Discovery of Ischemia After Replantation Surgery of the Extremities · NA · recruiting
- NCT03400345 — Human Upper Extremity Allotransplantation: F/U Protocol · recruiting
- NCT01459107 — Human Upper Extremity Allotransplantation · Phase 2 · recruiting
Other Gaziler Physical Medicine and Rehabilitation Education and Research Hospital trials
Trials by the same sponsor.
- NCT07207694 — WhatsApp-Based Education Program for Stroke Patients · NA · not yet recruiting
- NCT07472543 — Impact of Virtual Reality (VR) Based Exercises on Lower Limb Lymphedema Outcomes (LELO) · NA · recruiting
- NCT07507357 — Tidal Model Nursing for TBI Caregivers · NA · completed
- NCT07059468 — Osteoporosis After Stroke · completed
- NCT06917027 — Comparison of Mobile Education and Face-to-Face Intermittent Catheterization Education · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05188599 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Last refreshed: 13 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05188599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing